1-4 of 4
Kim M. Linton
Close
Sort by
Journal Articles

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Clinical Trials & Observations
Rohan Shotton, Rachel Broadbent, Alia Alchawaf, Mohamed Bakri Mohamed, Adam Gibb, Nicolás Martinez-Calle, Christopher P. Fox, Mark Bishton, Alexandra Pender, Mary Gleeson, David Cunningham, Andrew Davies, Sina Yadollahi, Toby A. Eyre, Graham Collins, Faouzi Djebbari, Shireen Kassam, Paula Garland, Emily Watts, Wendy Osborne, William Townsend, Rachael Pocock, Matthew J. Ahearne, Fiona Miall, Xin Wang, Kim M. Linton
Journal: Blood Advances
Blood Adv (2024) 8 (4): 878–888.
https://doi.org/10.1182/bloodadvances.2023011305
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

Clinical Trials & Observations
Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim M. Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Shir-Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6801–6811.
https://doi.org/10.1182/bloodadvances.2023010668
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial

Clinical Trials & Observations
Christopher P. Fox, Ayesha S. Ali, Graham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. Jackson, Louise M. Hopkins, Catherine M. Thomas, Shireen Kassam, Josh Wright, Sridhar Chaganti, Jeffery Smith, Ian Chau, Dominic Culligan, Kim M. Linton, Graham P. Collins, Andrés J. M. Ferreri, David Lewis, Andrew J. Davies, Rod Johnson, Dorothee P. Auer, Kate Cwynarski
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4073–4082.
https://doi.org/10.1182/bloodadvances.2021004779
Published: 2021
Includes: Supplemental data
Journal Articles

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Stephen Booth, Hannah Plaschkes, Amy A. Kirkwood, Adam Gibb, Patrick Horgan, Claire Higham, Joanna M. Oladipo, Joe Browning, Usman Khan, Bing Tseu, Lucia Chen, John Willan, Julia Wolf, Arief Gunawan, Paul Fields, Tim Ebsworth, Robert Lown, Dominic Gordon-Walker, Nimish Shah, Kim M. Linton, Graham P. Collins, Jaimal Kothari, Catherine Hildyard, Toby A. Eyre
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4337–4346.
https://doi.org/10.1182/bloodadvances.2020002553
Published: 2020
Includes: Supplemental data